Translational Drug Development

DBA TD2
Scottsdale, AZ 85259 · Professional & technical services · EIN 46-4150915
2024 plan yearFully insured

Translational Drug Development (Scottsdale, AZ, 161 participants) has a fully insured health plan with Cigna. Its broker of record is Amalyn Consulting, paid 11% of reported premium (median for this size: 4.4%). Coverage renews in April.

Participants
161
Renews
Apr
Schedule A premium
$1.1M
Broker comp
$123K
Comp rate
11%

Open in Open5500 →

Carriers by line

Insurance contracts (Schedule A)

LinesCarrierPolicy yearCoveredPremiumBroker compComp ratePaid to
Rx, Medical CignaApr 1, 2024
to Mar 31, 2025
163$703,600 $83,74212%
above typical · median 4.4%
Amalyn Consulting
Accident, AD&D, LTD, Critical Illness, STD, Life, Vision, Dental
Accidental Death and Dismemberment, Accident, Critical Illness
PrincipalApr 1, 2024
to Mar 31, 2025
269$371,955 $39,74311%
typical · median 11%
Amalyn Consulting

Brokers and agents paid

FirmLocationContractsCommissions + fees
Amalyn ConsultingScottsdale, AZ2$123,485

Plan-year history, 2022–2024

Plan yearParticipantsPremiumBroker compMedical fundingTop carriersBrokers
2024161$1.1M$123K Fully insuredCigna, Principal Amalyn Consulting
2023189$1.0M$127K Fully insuredCigna, Principal Amalyn Consulting
2022167$1.8M$110K Fully insuredBlue Cross Blue Shield (all plans), Principal Amalyn Consulting

Across all of this employer's welfare plans, as filed. Years with missing or partial filings show smaller totals.

Health and welfare plans

Plan #PlanPlan yearParticipantsReceivedOriginal
502Translational Drug Development (TD2) Welfare Benefit PlanApr 1, 2024 – Mar 31, 2025161Aug 27, 2025Filing PDF

Data as filed with the U.S. Department of Labor, through Oct 24, 2026. Something wrong? Report a data issue.